Skip to content
Search

Latest Stories

Weight-loss injections can cause gallstones, warns pharmacist

An increasing number of patients taking weight-loss injections are having their gallbladders removed, the pharmacist said.

More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.


“I'm seeing more and more patients taking weight-loss injections who then need their gallbladders removed,” she said.

Grayson, known as The Godmother of Pharmacology, explained how these drugs increased the risk of gallstone formation.

“The injections slow down the flow of bile through the gallbladder and delay emptying by suppressing the release of the hormone that controls it.

“This is one of the key ways in which it works. Unfortunately, this can also mean that in some people, this can make bile more sludgy and even lead to the formation of gallstones,” she warned.

According to Grayson, the risk of gallstone development could be as high as 1 in 10 people taking these drugs.

Deborah Grayson LinkedIn

Eli Lilly has already acknowledged gallbladder-related side effects in its safety warnings for Mounjaro, which is an injectable prescription medicine originally developed to manage blood sugar in adults with type 2 diabetes.

It is also authorised for use in weight loss and weight management in adults aged 18 and over, alongside a reduced-calorie diet and increased physical activity.

“Gallbladder problems have happened in some people who use Mounjaro,” the company said.

The company also listed other serious potential side effects, including:

  • Thyroid tumors, including thyroid cancer
  • Pancreatitis (inflammation of the pancreas)
  • Hypoglycemia (low blood sugar)
  • Severe allergic reactions
  • Kidney failure
  • Serious stomach issues
  • Changes in vision

These problemshave also been associated with other weight-loss jabs, such as Wegovy and Ozempic (semaglutide), both produced by Novo Nordisk.

Beware of the risk factors of gallstones

Grayson also highlighted other risk factors that could increase the risk of developing gallstones. These include being women, thyroid disease, menopausal or perimenopausal, and rapid weight loss.

“If any of these apply to you, it's important to look out for the signs that your gallbladder is struggling,” she said.

In a follow-up social media post, Grayson said that high cholesterol and poorly managed blood sugar are also risk factors and warned that “the more of these that apply the greater the risk.”

Symptoms of gallstones

Grayson advises patients taking the injections to be aware of the early warning signs of gallstones or sludgy bile that can lead to the stones forming. These include:

  • Acid reflux
  • Trapped wind and burping
  • Pain below the ribs
  • Left-sided shoulder pain
  • Abdominal pain
  • Diarrhoea or to a lesser extent constipation
  • Pale, greasy floaty stools
  • Bowel urgency

Patients experiencing these symptoms should seek medical advice promptly.

Before using weight loss jabs, it is advisable to inform your healthcare provider about any medical conditions you have and any medications you are taking to help prevent serious side effects.

More For You

NHS England reform: Community pharmacy is missing from the conversation, says Numark

Harry McQuillan, chairman of Numark

Abolition of NHS England – an opportunity for change, says Numark

Numark has welcomed prime minister Keir Starmer’s decision to abolish NHS England but emphasised the need to ensure community pharmacy is not overlooked in the restructuring.

Harry McQuillan, chairman of Numark, described the announcement as “a bold move” that signals a desire to put the NHS "back at the heart of government where it belongs.”

Keep ReadingShow less
national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
Discrimination: Asian and Black patients report lack of trust in primary care providers

Ethnic minority groups had worse experiences in their communication with their GP practice and felt taken less seriously

Getty Images

Survey reveals alarming rates of ethnic discrimination in NHS primary care

A recent survey by the NHS Race and Health Observatory has highlighted a worrying lack of trust in NHS primary care services among Black, Asian, and ethnic minority patients, who reported experiencing “racial or ethnic discrimination.”

Out of 2,680 survey respondents, only 55% reported trusting primary care providers to meet their health needs most or all of the time

Keep ReadingShow less